| Melanoma staging: evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual JE Gershenwald, RA Scolyer, KR Hess, VK Sondak, GV Long, MI Ross, ... CA: a cancer journal for clinicians 67 (6), 472-492, 2017 | 2234 | 2017 |
| Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers E Lim, F Vaillant, D Wu, NC Forrest, B Pal, AH Hart, ML Asselin-Labat, ... Nature medicine 15 (8), 907-913, 2009 | 1654 | 2009 |
| Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis P Savas, B Virassamy, C Ye, A Salim, CP Mintoff, F Caramia, R Salgado, ... Nature medicine 24 (7), 986-993, 2018 | 882 | 2018 |
| Tissue-resident memory CD8+ T cells promote melanoma–immune equilibrium in skin SL Park, A Buzzai, J Rautela, JL Hor, K Hochheiser, M Effern, N McBain, ... Nature 565 (7739), 366-371, 2019 | 341 | 2019 |
| Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy PA Beavis, MA Henderson, L Giuffrida, JK Mills, K Sek, RS Cross, ... The Journal of clinical investigation 127 (3), 929-941, 2017 | 307 | 2017 |
| Systemic therapy for melanoma: ASCO guideline R Seth, H Messersmith, V Kaur, JM Kirkwood, R Kudchadkar, ... Journal of Clinical Oncology 38 (33), 3947-3970, 2020 | 267 | 2020 |
| Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium RN Amaria, AM Menzies, EM Burton, RA Scolyer, MT Tetzlaff, ... The Lancet Oncology 20 (7), e378-e389, 2019 | 211 | 2019 |
| Desmoplastic melanoma: a pathologically and clinically distinct form of cutaneous melanoma WG Hawkins, KJ Busam, L Ben-Porat, KS Panageas, DG Coit, DE Gyorki, ... Annals of surgical oncology 12, 207-213, 2005 | 162 | 2005 |
| Management of primary retroperitoneal sarcoma (RPS) in the adult: an updated consensus approach from the Transatlantic Australasian RPS Working Group CJ Swallow, DC Strauss, S Bonvalot, P Rutkowski, A Desai, RA Gladdy, ... Annals of surgical oncology 28, 7873-7888, 2021 | 158 | 2021 |
| Prediction and monitoring of relapse in stage III melanoma using circulating tumor DNA L Tan, S Sandhu, RJ Lee, J Li, J Callahan, S Ftouni, N Dhomen, ... Annals of Oncology 30 (5), 804-814, 2019 | 148 | 2019 |
| Resident macrophages influence stem cell activity in the mammary gland DE Gyorki, ML Asselin-Labat, N van Rooijen, GJ Lindeman, JE Visvader Breast Cancer Research 11, 1-6, 2009 | 141 | 2009 |
| Global variation in postoperative mortality and complications after cancer surgery: a multicentre, prospective cohort study in 82 countries SR Knight, CA Shaw, R Pius, TM Drake, L Norman, AO Ademuyiwa, ... The Lancet 397 (10272), 387-397, 2021 | 140 | 2021 |
| Gata-3 negatively regulates the tumor-initiating capacity of mammary luminal progenitor cells and targets the putative tumor suppressor caspase-14 ML Asselin-Labat, KD Sutherland, F Vaillant, DE Gyorki, D Wu, S Holroyd, ... Molecular and cellular biology, 2011 | 140 | 2011 |
| Circulating tumor DNA analysis and functional imaging provide complementary approaches for comprehensive disease monitoring in metastatic melanoma SQ Wong, JM Raleigh, J Callahan, IA Vergara, S Ftouni, A Hatzimihalis, ... Precision Oncology 1, 1-14, 2017 | 115 | 2017 |
| Multiplex immunohistochemistry accurately defines the immune context of metastatic melanoma H Halse, AJ Colebatch, P Petrone, MA Henderson, JK Mills, H Snow, ... Scientific reports 8 (1), 11158, 2018 | 111 | 2018 |
| Neoadjuvant talimogene laherparepvec plus surgery versus surgery alone for resectable stage IIIB–IVM1a melanoma: a randomized, open-label, phase 2 trial R Dummer, DE Gyorki, J Hyngstrom, AC Berger, R Conry, L Demidov, ... Nature medicine 27 (10), 1789-1796, 2021 | 94 | 2021 |
| Sentinel lymph node biopsy for patients with cutaneous desmoplastic melanoma DE Gyorki, K Busam, K Panageas, MS Brady, DG Coit Annals of surgical oncology 10, 403-407, 2003 | 93 | 2003 |
| A community-based model of rapid autopsy in end-stage cancer patients K Alsop, H Thorne, S Sandhu, A Hamilton, C Mintoff, E Christie, O Spruyt, ... Nature biotechnology 34 (10), 1010-1014, 2016 | 88 | 2016 |
| Reprogramming the tumor microenvironment to enhance adoptive cellular therapy PA Beavis, CY Slaney, MH Kershaw, D Gyorki, PJ Neeson, PK Darcy Seminars in immunology 28 (1), 64-72, 2016 | 83 | 2016 |
| Prophylactic central neck dissection in differentiated thyroid cancer: an assessment of the evidence DE Gyorki, B Untch, RM Tuttle, AR Shaha Annals of Surgical Oncology 20, 2285-2289, 2013 | 76 | 2013 |
